Their immunohistochemical analysis of human CRC tissue samples revealed that CD24 expression increases with tumor progression and is strongly associated with the expression of p-ERK1/2 and p-p38 MAPK in the tissue (193). The gene discussed is CD24; the disease is neoplasm.